Shougang Fund
9
163M
9
0.69
2
1
- Areas of investment
Summary
Shougang Fund is the famous Corporate Investor, which was founded in 2011. The main office of represented Corporate Investor is situated in the Beijing. The fund was located in Asia if to be more exact in China.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Shougang Fund, startups are often financed by Matrix Partners China, H Capital Advance, Thiel Capital. The meaningful sponsors for the fund in investment in the same round are Yintai Group, YF Capital (Yunfeng Capital), Tencent Holdings. In the next rounds fund is usually obtained by Xing Wang, Tiantu Capital, SoftBank Investment Advisers.
Among the most popular portfolio startups of the fund, we may highlight Ouyeel, Immunochina. Among the most successful fund investment fields, there are Biotechnology, Energy. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China.
The top activity for fund was in 2018. Considering the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Shougang Fund is 500 millions - 1 billion dollars. The common things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 0.69
- Investments by industry
- Automotive (3)
- Medical Device (2)
- Medical (2)
- Manufacturing (2)
- Artificial Intelligence (2) Show 23 more
- Investments by region
-
- China (9)
- Peak activity year
- 2018
- Number of Unicorns
- 3
- Number of Decacorns
- 3
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 1.00
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Huiyi Huiying | 16 Nov 2020 | Artificial Intelligence, Health Care, Hospital, Big Data, Medical Device, Medical, Cloud Computing | Late Stage Venture | 15M | Beijing, Dongcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.